STAT Plus: Pharmalittle: Generic shortages loom as coronavirus worsens; Connecticut lawmakers look to cap insulin costs
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Despite the long weekend coming up on this side of the pond, our agenda is rather modest. We plan to spend time with Mrs. Pharmalot, hang with a short person or two, and look in on the Pharmalot ancestors. And maybe catch up on some reading. And what about you? This is a fine time to take in a moving picture. You could prepare your taxes — remember, someone has to pay for that White House budget. Or you could make time for someone special. This is the time of year to acknowledge that sweet person in your life. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you on Tuesday.
Americans with private employer health insurance spent nearly 26% more on prescription drugs from 2014 to 2018, STAT writes, citing a new analysis. At the same time, the average price of a medicine purchased by each employee rose by almost 21% and their usage rose more than 4% during that time period. Moreover, the rate at which prescription drug spending rose also outpaced the increased cost of other medical services, such as doctor visits and hospital admissions, during those five years.
Continue to STAT Plus to read the full story…
